How quickly does Zembrace work?
Zembrace SymTouch (sumatriptan injection) starts relieving migraine symptoms within 10-15 minutes after subcutaneous injection, with peak effects around 1 hour. About 67-82% of patients report pain relief by 1-2 hours post-dose.[1][2]
How does it compare to oral triptans?
Unlike oral sumatriptan (which takes 30-60 minutes to onset), Zembrace's needle-free autoinjector delivers it faster via subcutaneous route, mimicking needle-based versions like Imitrex Statdose. This makes it faster-acting than pills or nasal sprays for acute migraine attacks.[1][3]
What's the dosing for fastest relief?
Standard dose is 3 mg injected under the skin; repeat after 1 hour if needed (max 12 mg/day). It uses a prefilled syringe with a ½-inch needle for quick self-administration.[1]
Who makes Zembrace and when did it launch?
Promius Pharma (a subsidiary of Dr. Reddy's Laboratories) developed Zembrace, FDA-approved in 2016 as a faster, easier alternative to older injectables.[1][4]
Common side effects with quick onset use?
Injection-site reactions (pain, redness) occur in ~60% of users, plus typical triptan effects like chest tightness or dizziness. Effects resolve quickly as the drug peaks fast.[1][2]
Patent status and generic availability?
Zembrace's key patents cover the autoinjector and formulation, expiring around 2030-2033 per DrugPatentWatch.com. No generics yet, but challenges could accelerate entry.[5]
[1]: Zembrace SymTouch Prescribing Information, Promius Pharma (promiuspharma.com).
[2]: FDA Label, NDA 207990 (accessdata.fda.gov).
[3]: Sumatriptan Clinical Pharmacology Review, FDA (2016).
[4]: Promius Pharma Press Release, Jan 2016 (promiuspharma.com).
[5]: DrugPatentWatch.com (drugpatentwatch.com/p/tradename/ZEMBRACE).